Projects per year
Organization profile
Organization profile
A unit of the Academic Health Center, Molecular and Cellular Therapeutics offers state-of-the-art GMP/GTP compliant, full-service development and manufacturing of cell- and tissue-based products, monoclonal antibodies and other therapeutic proteins, as well as active pharmaceutical ingredients, for use in Phase I, II or III clinical trials. Our fully-staffed technical and quality personnel with over 70 years of combined cell-based products experience, through product development and technical expertise, as well as medical and regulatory support, work to compress development timelines and translate research into medicine.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Molecular and Cellular Therapeutics is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Diane M Kadidlo
- Molecular and Cellular Therapeutics - Research Director
- Office of Academic Clinical Affairs
Person: Research Support
-
-
-
PACT - Preclinical development of PB-drevived iTregs
McKenna, D. H. (PI)
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
11/1/19 → 3/31/22
Project: Research project
-
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
MacMillan, M. L., Hippen, K. L., McKenna, D. H., Kadidlo, D. M., Sumstad, D., Defor, T. E., Brunstein, C. G., Holtan, S. G., Miller, J. S., Warlick, E. D., Weisdorf, D. J., Wagner, J. E. & Blazar, B. R., Mar 9 2021, In: Blood Advances. 5, 5, p. 1425-1436 12 p.Research output: Contribution to journal › Article › peer-review
Open Access41 Scopus citations -
Optimization of cGMP purification and expansion of umbilical cord blood–derived T-regulatory cells in support of first-in-human clinical trials
McKenna, D. H., Sumstad, D., Kadidlo, D. M., Batdorf, B., Lord, C. J., Merkel, S. C., Koellner, C. M., Curtsinger, J. M., June, C. H., Riley, J. L., Levine, B. L., Miller, J. S., Brunstein, C. G., Wagner, J. E., Blazar, B. R. & Hippen, K. L., Feb 1 2017, In: Cytotherapy. 19, 2, p. 250-262 13 p.Research output: Contribution to journal › Article › peer-review
Open Access41 Scopus citations -
Clinical mesenchymal stromal cell products undergo functional changes in response to freezing
Pollock, K., Sumstad, D., Kadidlo, D., McKenna, D. H. & Hubel, A., Jan 1 2015, In: Cytotherapy. 17, 1, p. 38-45 8 p.Research output: Contribution to journal › Article › peer-review
Open Access50 Scopus citations